Colistimethate Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 23155-193

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Colistimethate Sodium (NDC 23155-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

059ead12 D70d 4fec A558 05362691248d 01

Chemical structure diagram of colistimethate sodium showing its peptide chain with multiple sulfomethyl groups attached to L-Dbu residues. This represents the active ingredient colistimethate sodium in the pharmaceutical product.*

FDA Label Image

059ead12 D70d 4fec A558 05362691248d 02

A line graph showing urine and serum colistin base activity levels in micrograms per milliliter over a 12-hour period following intramuscular (IM) and intravenous (IV) administration of Colistimethate for Injection, USP in adults. The graph displays distinct trends for urine and serum concentrations for both administration routes.*

FDA Label Image

059ead12 D70d 4fec A558 05362691248d 03

FDA Label Image

059ead12 D70d 4fec A558 05362691248d 04

Label for Colistimethate for Injection, USP, showing a single dose vial containing 150 mg per vial of colistimethate sodium. The label indicates use for intramuscular and intravenous administration. It includes storage instructions, manufacturer information (Emcure Pharmaceuticals Ltd. for Avet Pharmaceuticals Inc.), and a barcode with NDC 23155-193-31.*

FDA Label Image

059ead12 D70d 4fec A558 05362691248d 05

Colistimethate Sodium 150 mg per vial injection label for intramuscular and intravenous use. The lyophilized powder for solution vial label shows dosage strength, administration routes, and manufacturer Heritage Pharmaceuticals Inc. dba Avet Pharmaceuticals Inc. The label includes usage instructions, storage conditions, and barcode information.*

FDA Label Image

059ead12 D70d 4fec A558 05362691248d 06

The packaging label for Colistimethate injection, USP, 150 mg per vial, lyophilized powder for solution. It is indicated for intramuscular and intravenous use, available in a carton of 12 single-dose vials. The labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label includes dosing information and storage instructions. The NDC number 23155-193-41 is visible, and the product is manufactured by Emcure Pharmaceuticals Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.